NCT05460845

Brief Summary

Phantom limb pain (PLP) is defined as pain or discomfort in a missing limb following amputation, whereas residual limb pain (RLP) is often experienced as pain at the site of amputation. Unfortunately, PLP can affect as many as 80% of upper- or lower-extremity amputees, with 40-60% also experiencing RLP. There are many theories regarding the mechanisms underlying these types of pain, but effective treatments remain elusive .Amputation of a limb is often accompanied by a traumatic event that can be emotionally devastating. Consequently, studies have reported high levels of depression in this population, up to 80%. Other studies have reported elevated levels of depression (70%), suicidality (30%) and posttraumatic stress disorder (PTSD, 20%) with PTSD being highly correlated with PLP. Thus, it is critical that effective treatments be employed that address, not only the chronic pain, but the comorbid conditions as well. Diet interventions have been utilized as a non-pharmacological method to reduce pain and/or inflammation. We have shown that a low-carbohydrate diet (LCD) reduced pain independent of weight loss. Importantly, we observed a reduction in depressive symptomology and improved quality of life (QOL) following the LCD. Thus, it is reasonable to expect that the LCD may have beneficial effects of pain experience and also on measures of QOL. Phase 1: To characterize the dietary habits, pain severity and psychological well-being of the local amputee population. Hypotheses: We expect that the local population will show high prevalence of phantom limb pain (PLP) and/or residual limb pain (RLP). Self-report of depressive symptomology, poor-quality diet, will coincide with low QOL reports. Phase 2: To assess the feasibility and efficacy of a low-carbohydrate diet (LCD) to reduce pain and increase QOL in amputees. Hypotheses: All participants will complete the 6-week LCD. Compared to baseline, a 6-week LCD will reduce self-reports of pain and depressive symptoms. Overall QOL will improve over 6 weeks with concomitant improved mood and sleep.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2022

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 15, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 28, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 28, 2023

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

1.2 years

First QC Date

July 13, 2022

Last Update Submit

August 28, 2023

Conditions

Outcome Measures

Primary Outcomes (3)

  • BPI Pain Severity Change

    BPI pain severity is an average score out of 10.

    Baseline (week 0), immediately after the intervention (week 6)

  • BPI Pain Interference Change

    BPI pain interference is an average score from 9 items out of 10.

    Baseline (week 0), immediately after the intervention (week 6)

  • SF-36 overall score change

    The Short Form 36 (SF-36) quality of life score is a 0-150 score with higher scores reflecting poorer quality of life. Scores in each of the 7 sections (general health, limitations, physical health, emotional health, social activities, pain and energy) are summed to provide an overall quality of life score. Change scores will be calculated.

    Baseline (week 0), immediately after the intervention (week 6)

Secondary Outcomes (9)

  • NPQ score change

    Baseline (week 0), immediately after the intervention (week 6)

  • CES-D score change

    Baseline (week 0), immediately after the intervention (week 6)

  • PSQI change score

    Baseline (week 0), immediately after the intervention (week 6)

  • NEADL change score

    Baseline (week 0), immediately after the intervention (week 6)

  • PROMIS-57 domain change

    Baseline (week 0), immediately after the intervention (week 6)

  • +4 more secondary outcomes

Other Outcomes (1)

  • Weight change

    Baseline (week 0), immediately after the intervention (week 6)

Study Arms (1)

Phase 2 Intervention

EXPERIMENTAL

Low-Carbohydrate Diet

Behavioral: Low-Carbohydrate Diet

Interventions

Using a meal delivery service and a list of prepared meals and recipes, foods/meals will be delivered to participants weekly to maintain daily net carbohydrate intake to less than 40 grams.

Also known as: LCD
Phase 2 Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Amputation at least 6 months prior

You may not qualify if:

  • Inability to read/understand English
  • Active infection at amputation site
  • PLP/RLP for at least 6 months (\>4/10 on visual analogue scale)
  • Amputation at least 6 months prior
  • Inability to read/understand English
  • Current infection at amputation site
  • Unmedicated diabetes
  • Unwillingness to follow prescribed diet
  • Recent weight change (\>4 kg in past month)
  • Currently on a prescribed diet or consuming less than 100 g of daily carbohydrates
  • History of eating disorders or other psychiatric disorders requiring hospitalization within the past 6 months
  • Digestive diseases
  • Difficulty chewing or swallowing
  • Reliance on others for meal preparation
  • Uncontrolled cardiovascular or pulmonary disease
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States

Location

MeSH Terms

Conditions

Phantom Limb

Interventions

Diet, Carbohydrate-Restricted

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPain

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 13, 2022

First Posted

July 15, 2022

Study Start

July 1, 2022

Primary Completion

August 28, 2023

Study Completion

August 28, 2023

Last Updated

August 30, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will share

Following our extended analysis period, de-identified data will be made available, as well as the variable key, to the scientific community. Before this time, a request for data sharing will be assessed by study personnel (PI and Co-Is) as needed. These requests will be evaluated based on scientific merit and overlap with the aims of the current study.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
For 5 years following final data analysis
Access Criteria
De-identified data can be made available on encrypted servers for researchers whose research plans do not overlap with the aims of the current project. Requests will be assessed by the PI and Co-Is as needed.

Locations